Document is current
Any future updates will be listed below
-
Authors
Cohen Tervaert, Jan Willem https://orcid.org/0000-0001-7407-6364
van Eeden, Charmaine
Butt, Imama
Redmond, Desiree
Clifford, Alison
Osman, Mo
Yacyshyn, Elaine
- License Information
-
More Information
Article History
Received: 21 March 2023
Revised: 21 March 2023
Accepted: 26 March 2023
First Online: 1 April 2023
Declarations
:
: Dr. Cohen Tervaert’s and Dr. Osman’s research are supported by unrestricted grants from the University of Alberta (Canada), Dutch Kidney Foundation, the University Hospital Foundation and Kaye Grants, Scleroderma Canada, and Boehringer Ingelheim. Additionally, Dr. Osman is funded by the Arthritis Society (STAR/IMHA career development award 00049).Cohen Tervaert is an Expert member of the screening panel for medical devices of the European Union. Furthermore, Cohen Tervaert appeared as an expert witness in court for patients with adverse effects due to biomaterials (arthroplasty, mesh, and breast implants), received speaker fees from Pfizer, Sanofi, AbbVie, Medarex, Hoffmann-La Roche, GSK and consulting fees from Merck, Novartis, Mallinckrodt Pharmaceuticals. Dr. Osman received speaker honoraria from Boehringer Ingelheim. The other authors have nothing to disclose.
